T.F. Lüscher

Discipline

Psychologie (5)

Type de document

Articles (30) Recensions (4)

Co-auteur

Date

Source

Mot-clé

Patients (23) Patients (23) Syndromes (19) Human beings (19) risque (17) Risk (17) cohorte (15) Ci (Chinese poetry) (13) Year (12) Treatment (11) association (9) Social groups (9) Myocardial infarction (9) Older people (9) mortalité (8) Mortality (8) Death (8) Rates (8) Mortality (8) Death (8) Rates (8) mort (8) roman (8) temps (durée) (7) thérapie (7) maladie (7) âge (7) procès (7) Time (7) Therapeutics (7)

Documents écrit par T.F. Lüscher (30) | parle de T.F. Lüscher (0)

History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbidities.
A. Denegri et al. (1 juil. 2023)
Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis.
S. Kraler et al.
Smoking Cessation in People With and Without Diabetes After Acute Coronary Syndrome.
L. Clement et al. (1 janv. 2023)
Smoking cessation and depression after acute coronary syndrome.
K. Krasieva et al.
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation.
F.A. Wenzl et al. (3 sept. 2022)
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study.
L. Gilgien-Dénéréaz et al. (18 juil. 2022)
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in Switzerland.
I. Worni-Schudel et al.
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
R. Klingenberg et al. (19 oct. 2021)
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients.
T. Mahendiran et al.
Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic Dissection.
A. Forrer et al. (30 mars 2021)
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
R. Klingenberg et al.
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.
F. Mahfoud et al. (21 avr. 2020)
Optimal Timing of Invasive Coronary Angiography following NSTEMI.
T. Mahendiran et al. (2020)
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
P. Winzap et al. (31 oct. 2019)
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes.
N. Vuilleumier et al. (9 juil. 2019)
Association between income and control of cardiovascular risk factors after acute coronary syndromes: an observational study.
E. Jaquet et al. (8 avr. 2019)
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention.
D. Carballo et al. (2019)
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.
K.C. Koskinas et al. (13 avr. 2018)
Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.
F. Mahfoud et al. (21 nov. 2017)
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.
B. Gencer et al. (9 nov. 2017)
Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons.
R. Auer et al. (20 sept. 2016)
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
R. Laaksonen et al. (1 juil. 2016)
Health utility indexes in patients with acute coronary syndromes.
B. Gencer et al. (2016)
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.
F. Mahfoud et al. (2015)
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
D. Nanchen et al. (2015)

next